Gene: PAPPA
Official Full Name: pappalysin 1provided by HGNC
Gene Summary: This gene encodes a secreted metalloproteinase which cleaves insulin-like growth factor binding proteins (IGFBPs). Following IGFBP cleavage, insulin growth factors dissociate from IGFBPs and bind to IGF receptors, resulting in activation of the IGF pathway. The encoded protein plays a role in bone formation, inflammation, wound healing and female fertility. Enhanced expression of this protein is associated with diabetic nephropathy in human patients and this protein may promote tumor invasion and growth in various human cancers. [provided by RefSeq, Aug 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36228 | PAPPA Knockout cell line (HeLa) | Human | PAPPA | 1:3~1:6 | Negative | Online Inquiry |
KO36229 | PAPPA Knockout cell line (A549) | Human | PAPPA | 1:3~1:4 | Negative | Online Inquiry |
PAPPA Gene Knockout Cell Lines are specialized cell models engineered to lack the expression of the PAPPA (Pappalysin-1) gene, which encodes a metalloproteinase that is crucial in regulating the activity of insulin-like growth factor (IGF) and its associated signaling pathways. By providing researchers with the ability to study the specific effects of PAPPA gene deletion, these cell lines serve as powerful tools for understanding the role of IGF in growth, development, and various pathologies, including cancer and metabolic disorders.
The primary function of PAPPA involves enhancing the bioavailability of IGF by cleaving its binding proteins, thus influencing the IGF signaling pathway that plays a significant role in cell proliferation and anti-apoptotic processes. In the absence of PAPPA, researchers can directly assess changes in cellular behavior, gene expression, and metabolic signaling pathways, facilitating insights into its contributions to disease mechanisms.
The scientific importance of PAPPA Gene Knockout Cell Lines extends to both research and clinical settings. In academic labs, these models are invaluable for dissecting the molecular underpinnings of diseases associated with aberrations in IGF signaling, while in clinical research, they offer potential for developing targeted therapeutic strategies. Their employment in drug discovery and development may pave the way for groundbreaking treatments for conditions like cancer and diabetes.
Compared to conventional models, these knockout cell lines provide a cleaner and more focused approach to studying gene function without the confounding effects of endogenous PAPPA expression. Additionally, they are designed for ease of use with standardized protocols for transfection and characterization, ensuring consistent results and reproducibility—the cornerstones of rigorous scientific inquiry.
For researchers and clinicians, the PAPPA Gene Knockout Cell Lines represent not just a product, but a pathway to unraveling complex biological relationships and developing innovative treatments. Our company, with a robust background in molecular biology and genetic engineering, stands behind these cell lines, providing not only high-quality biological products but also extensive technical support and expertise to maximize their utility in your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.